董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Michael J. Weiss | -- | Director | 75 | 7.51万美元 | 0.42 | 2026-01-08 |
| Markus W. Sieger | 男 | Director | 60 | 未披露 | 未持股 | 2026-01-08 |
| Susan Y. Bernstein | 女 | Director | 62 | 未披露 | 未持股 | 2026-01-08 |
| Mark Stein | -- | Director | 54 | 3.13万美元 | 未持股 | 2026-01-08 |
| Markus W. Sieger | -- | Director | 60 | 未披露 | 未持股 | 2026-01-08 |
| Alan Grayson | 男 | Director | 68 | 未披露 | 未持股 | 2026-01-08 |
| Howard S. Jonas | 男 | Chief Executive Officer and Director and Executive Chairman and President | 70 | 29.40万美元 | 573.10 | 2026-01-08 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David Polinsky | 男 | Chief Financial Officer | 55 | 52.74万美元 | 1.30 | 2026-01-08 |
| Howard S. Jonas | 男 | Chief Executive Officer and Director and Executive Chairman and President | 70 | 29.40万美元 | 573.10 | 2026-01-08 |
董事简历
中英对照 | 中文 | 英文- Michael J. Weiss
-
MichaelJ.Weiss自2018年3月起担任董事，自1985年起担任爱德华·哈克尼斯眼科研究所眼科医生，自1987年7月起担任葡萄膜炎服务董事。Weiss博士是哥伦比亚大学医学中心（Columbia University Medical Center）的眼科临床教授，并于1987年6月获得眼科董事会认证。Weiss博士于1972年在以色列巴伊兰大学（Bar-Ilan University）获得理学士学位，于1976年在哥伦比亚大学艺术与科学学院（Columbia University School of Arts and Sciences）获得博士学位，并于1981年在哥伦比亚医学院（Columbia College of Physicians and Surgeons）获得医学博士学位。1976年至1977年，Weiss博士还在哥伦比亚大学癌症研究所（Columbia University Institute of Cancer Research）获得研究生奖学金。
Michael J. Weiss,has served as a director since March 2018 and has been on staff as an ophthalmologist with the Edward S. Harkness Eye Institute since 1985 and has served as a director of Uveitis Service since July 1987. Dr. Weiss is a Clinical Professor of Ophthalmology at Columbia University Medical Center and was Board Certified in Ophthalmology in June 1987. Dr. Weiss received a Bachelor of Science from Bar-Ilan University, Israel in 1972, a Ph.D. from Columbia University School of Arts and Sciences in 1976 and a M.D. from Columbia College of Physicians and Surgeons in 1981. Dr. Weiss also did a Post-Graduate Fellowship at Columbia University Institute of Cancer Research from 1976-1977. - MichaelJ.Weiss自2018年3月起担任董事，自1985年起担任爱德华·哈克尼斯眼科研究所眼科医生，自1987年7月起担任葡萄膜炎服务董事。Weiss博士是哥伦比亚大学医学中心（Columbia University Medical Center）的眼科临床教授，并于1987年6月获得眼科董事会认证。Weiss博士于1972年在以色列巴伊兰大学（Bar-Ilan University）获得理学士学位，于1976年在哥伦比亚大学艺术与科学学院（Columbia University School of Arts and Sciences）获得博士学位，并于1981年在哥伦比亚医学院（Columbia College of Physicians and Surgeons）获得医学博士学位。1976年至1977年，Weiss博士还在哥伦比亚大学癌症研究所（Columbia University Institute of Cancer Research）获得研究生奖学金。
- Michael J. Weiss,has served as a director since March 2018 and has been on staff as an ophthalmologist with the Edward S. Harkness Eye Institute since 1985 and has served as a director of Uveitis Service since July 1987. Dr. Weiss is a Clinical Professor of Ophthalmology at Columbia University Medical Center and was Board Certified in Ophthalmology in June 1987. Dr. Weiss received a Bachelor of Science from Bar-Ilan University, Israel in 1972, a Ph.D. from Columbia University School of Arts and Sciences in 1976 and a M.D. from Columbia College of Physicians and Surgeons in 1981. Dr. Weiss also did a Post-Graduate Fellowship at Columbia University Institute of Cancer Research from 1976-1977.
- Markus W. Sieger
-
Markus W. Sieger，自2014年2月起担任公司董事，并担任公司董事会主席。Sieger先生是斯坦福大学商学院的校友，拥有苏黎世工商管理应用科学大学的经济学学位。他是一位经验丰富的企业家和高级管理人员，在美国、瑞士、波兰和中东欧其他国家的医疗保健、信息技术、数字媒体和快速消费品等新兴行业拥有多个行业的经验。他曾在苏黎世保险集团（瑞士）、TVN（波兰）等公司担任管理职务。他曾是美国和欧洲多家上市公司和私营公司的董事会成员。自2016年6月以来，Sieger先生一直担任Polpharma Group（荷兰）的首席执行官，该公司是中东欧/独联体地区领先的医疗保健公司之一。Sieger先生是欧洲药品执行委员会副主席，代表欧盟的仿制药行业。在这一职能中，Sieger先生侧重于医疗保健的数字化和预防方面。
Markus W. Sieger,has been a Director of the Company since February 2014 and serves as the Chairman of the Company's Board of Directors. Mr. Sieger is an alumnus of the Stanford Graduate School of Business and holds a degree in Economics from the University of Applied Sciences for Business and Administration Zurich. He is a seasoned entrepreneur and senior executive with a multi-industry experience in emerging industries like healthcare, information technology, digital media and fast-moving consumer goods in the United States, Switzerland, Poland, and other countries in Central and Eastern Europe. He held management roles in companies such as Zurich Insurance Group (Switzerland), TVN (Poland) and several others. He was and is a member of the boards of directors of various public and private companies in the United States and Europe. Since June 2016 Mr. Sieger has been CEO of Polpharma Group (Netherlands), one of the leading healthcare companies in the CEE/CIS region. Mr. Sieger is vice-president of the Executive Board of Medicines for Europe, representing the generics industry to the European Union. In this function Mr. Sieger focuses on digitalization and preventive aspects of healthcare. - Markus W. Sieger，自2014年2月起担任公司董事，并担任公司董事会主席。Sieger先生是斯坦福大学商学院的校友，拥有苏黎世工商管理应用科学大学的经济学学位。他是一位经验丰富的企业家和高级管理人员，在美国、瑞士、波兰和中东欧其他国家的医疗保健、信息技术、数字媒体和快速消费品等新兴行业拥有多个行业的经验。他曾在苏黎世保险集团（瑞士）、TVN（波兰）等公司担任管理职务。他曾是美国和欧洲多家上市公司和私营公司的董事会成员。自2016年6月以来，Sieger先生一直担任Polpharma Group（荷兰）的首席执行官，该公司是中东欧/独联体地区领先的医疗保健公司之一。Sieger先生是欧洲药品执行委员会副主席，代表欧盟的仿制药行业。在这一职能中，Sieger先生侧重于医疗保健的数字化和预防方面。
- Markus W. Sieger,has been a Director of the Company since February 2014 and serves as the Chairman of the Company's Board of Directors. Mr. Sieger is an alumnus of the Stanford Graduate School of Business and holds a degree in Economics from the University of Applied Sciences for Business and Administration Zurich. He is a seasoned entrepreneur and senior executive with a multi-industry experience in emerging industries like healthcare, information technology, digital media and fast-moving consumer goods in the United States, Switzerland, Poland, and other countries in Central and Eastern Europe. He held management roles in companies such as Zurich Insurance Group (Switzerland), TVN (Poland) and several others. He was and is a member of the boards of directors of various public and private companies in the United States and Europe. Since June 2016 Mr. Sieger has been CEO of Polpharma Group (Netherlands), one of the leading healthcare companies in the CEE/CIS region. Mr. Sieger is vice-president of the Executive Board of Medicines for Europe, representing the generics industry to the European Union. In this function Mr. Sieger focuses on digitalization and preventive aspects of healthcare.
- Susan Y. Bernstein
-
Susan Y. Bernstein，自2018年以来，Bernstein女士担任Best Western PLUS Morristown Inn的共同所有人/销售和营销总监，该酒店是猫途鹰上Morristown排名第一的酒店。从2013年11月到2017年9月，伯恩斯坦女士担任414酒店的总经理和所有者，带领该酒店在猫途鹰上成为纽约市排名第一的酒店，并在那里保持了两年直到被出售。伯恩斯坦女士此前曾担任全球旅游公司Signature Tours的销售经理。Bernstein女士获得了波士顿大学的传播和市场营销学士学位。
Susan Y. Bernstein,Since 2018, Ms. Bernstein has served as Co-Owner/Director of Sales and Marketing for the Best Western PLUS Morristown Inn which is the #1 hotel in Morristown on TripAdvisor. From November 2013 through September 2017, Ms. Bernstein served as General Manager and owner of 414 Hotel, leading the hotel to the ranking as the #1 hotel in New York City on TripAdvisor where it remained for two years until it was sold. Ms. Bernstein had previously served as Sales Manager for Signature Tours, a worldwide tour company. Ms. Bernstein received a B.A. in Communications and Marketing from Boston University. - Susan Y. Bernstein，自2018年以来，Bernstein女士担任Best Western PLUS Morristown Inn的共同所有人/销售和营销总监，该酒店是猫途鹰上Morristown排名第一的酒店。从2013年11月到2017年9月，伯恩斯坦女士担任414酒店的总经理和所有者，带领该酒店在猫途鹰上成为纽约市排名第一的酒店，并在那里保持了两年直到被出售。伯恩斯坦女士此前曾担任全球旅游公司Signature Tours的销售经理。Bernstein女士获得了波士顿大学的传播和市场营销学士学位。
- Susan Y. Bernstein,Since 2018, Ms. Bernstein has served as Co-Owner/Director of Sales and Marketing for the Best Western PLUS Morristown Inn which is the #1 hotel in Morristown on TripAdvisor. From November 2013 through September 2017, Ms. Bernstein served as General Manager and owner of 414 Hotel, leading the hotel to the ranking as the #1 hotel in New York City on TripAdvisor where it remained for two years until it was sold. Ms. Bernstein had previously served as Sales Manager for Signature Tours, a worldwide tour company. Ms. Bernstein received a B.A. in Communications and Marketing from Boston University.
- Mark Stein
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Markus W. Sieger
-
暂无中文简介
has been a Director of the Company since March 2025 when Mr. Sieger was appointed in connection with the closing of the merger with Cyclo and, from February 2014 until March 2025, served as Chairman of the Board of Cyclo. Mr. Sieger is a seasoned entrepreneur and senior executive with multi-industry experience in emerging industries like healthcare, information technology, digital media and fast-moving consumer goods in the United States, Switzerland, Poland, and other countries in Central and Eastern Europe. He has held management roles in companies such as Zurich Insurance Group (Switzerland, USA), TVN (Poland) and several others. He was and is a member of the boards of directors of various public and private companies in the United States and Europe. Since June 2016, Mr. Sieger has been Chief Executive Officer of Polpharma Group (Netherlands), one of the leading healthcare companies in Central and Eastern Europe. Mr. Sieger is vice-president of the Executive Board of Medicines for Europe, representing the generic pharmaceutical industry to the European Union. In this function, Mr. Sieger focuses on digitalization and preventive aspects of healthcare. Mr. Sieger is an alumnus of the Stanford Graduate School of Business and holds a degree in Economics from the University of Applied Sciences for Business and Administration Zurich. -
暂无中文简介
- has been a Director of the Company since March 2025 when Mr. Sieger was appointed in connection with the closing of the merger with Cyclo and, from February 2014 until March 2025, served as Chairman of the Board of Cyclo. Mr. Sieger is a seasoned entrepreneur and senior executive with multi-industry experience in emerging industries like healthcare, information technology, digital media and fast-moving consumer goods in the United States, Switzerland, Poland, and other countries in Central and Eastern Europe. He has held management roles in companies such as Zurich Insurance Group (Switzerland, USA), TVN (Poland) and several others. He was and is a member of the boards of directors of various public and private companies in the United States and Europe. Since June 2016, Mr. Sieger has been Chief Executive Officer of Polpharma Group (Netherlands), one of the leading healthcare companies in Central and Eastern Europe. Mr. Sieger is vice-president of the Executive Board of Medicines for Europe, representing the generic pharmaceutical industry to the European Union. In this function, Mr. Sieger focuses on digitalization and preventive aspects of healthcare. Mr. Sieger is an alumnus of the Stanford Graduate School of Business and holds a degree in Economics from the University of Applied Sciences for Business and Administration Zurich.
- Alan Grayson
-
艾伦·格雷森，曾于2009年至2011年和2013年至2017年担任国会议员。在他的第一个任期内，他曾在金融服务委员会任职。除了Grayson先生担任国会议员的那些年，Grayson先生自1991年以来一直是政府合同和举报人律师，是一名单独执业人员，并在Grayson & Associates，P.C.和Grayson，Kubli & Hoffman，P.C.任职。1990-1991年，Grayson先生担任IDT公司总裁。Grayson先生曾在1983年至1985年期间担任法院法律书记员，与Ruth Bader Ginsburg和Antonin Scalia法官共事。从1985年到1990年，格雷森先生在弗里德·弗兰克·哈里斯·施莱弗和雅各布森公司担任政府合同律师。1986年，Grayson先生与他人共同创立了老龄化研究联盟，并担任了二十多年的军官…1978年，格雷森先生获得了哈佛学院的学士学位（高荣誉），并于1983年获得了哈佛大学的法学博士学位（荣誉）和M.P.P.。
Alan Grayson,was a Member of Congress from 2009 to 2011 and 2013 to 2017. In his first term, he served on the Financial Services Committee. Other than Mr. Grayson's years as a member of Congress, Mr. Grayson has been a government contracts and whistleblower attorney as a solo practitioner and with Grayson & Associates, P.C. and Grayson, Kubli & Hoffman, P.C. since 1991. From 1990-1991, Mr. Grayson served as President of IDT Corporation. Mr. Grayson worked as a court law clerk from 1983 to 1985, working with Judges Ruth Bader Ginsburg and Antonin Scalia. From 1985 to 1990, Mr. Grayson worked as a government contracts attorney at Fried Frank Harris Shriver and Jacobson. In 1986, Mr. Grayson co-founded the Alliance for Aging Research, and served as an officer for more than twenty years.. In 1978, Mr. Grayson received a B.A. (high honors) from Harvard College, and a J.D. (with honors) and a M.P.P from Harvard University in 1983. - 艾伦·格雷森，曾于2009年至2011年和2013年至2017年担任国会议员。在他的第一个任期内，他曾在金融服务委员会任职。除了Grayson先生担任国会议员的那些年，Grayson先生自1991年以来一直是政府合同和举报人律师，是一名单独执业人员，并在Grayson & Associates，P.C.和Grayson，Kubli & Hoffman，P.C.任职。1990-1991年，Grayson先生担任IDT公司总裁。Grayson先生曾在1983年至1985年期间担任法院法律书记员，与Ruth Bader Ginsburg和Antonin Scalia法官共事。从1985年到1990年，格雷森先生在弗里德·弗兰克·哈里斯·施莱弗和雅各布森公司担任政府合同律师。1986年，Grayson先生与他人共同创立了老龄化研究联盟，并担任了二十多年的军官…1978年，格雷森先生获得了哈佛学院的学士学位（高荣誉），并于1983年获得了哈佛大学的法学博士学位（荣誉）和M.P.P.。
- Alan Grayson,was a Member of Congress from 2009 to 2011 and 2013 to 2017. In his first term, he served on the Financial Services Committee. Other than Mr. Grayson's years as a member of Congress, Mr. Grayson has been a government contracts and whistleblower attorney as a solo practitioner and with Grayson & Associates, P.C. and Grayson, Kubli & Hoffman, P.C. since 1991. From 1990-1991, Mr. Grayson served as President of IDT Corporation. Mr. Grayson worked as a court law clerk from 1983 to 1985, working with Judges Ruth Bader Ginsburg and Antonin Scalia. From 1985 to 1990, Mr. Grayson worked as a government contracts attorney at Fried Frank Harris Shriver and Jacobson. In 1986, Mr. Grayson co-founded the Alliance for Aging Research, and served as an officer for more than twenty years.. In 1978, Mr. Grayson received a B.A. (high honors) from Harvard College, and a J.D. (with honors) and a M.P.P from Harvard University in 1983.
- Howard S. Jonas
-
Howard S. Jonas自2011年1月担任公司董事会主席，2014年1月至2017年11月担任公司首席执行官。他自2009年9月起担任公司子公司Genie Energy International Corporation董事会联席副主席。Jonas先生于1990年8月创立了IDT公司，自成立以来一直担任董事会主席。Jonas先生在2009年10月至2013年12月期间担任IDT首席执行官。Jonas先生担任Zedge，Inc.董事会主席，该公司是IDT的前子公司，于2016年6月至2016年11月分拆给股东，自2016年11月起担任Zedge董事会副主席。Jonas还担任IDW媒体控股公司（IDW Media Holdings，Inc.）董事会主席，该公司曾是IDT的子公司，2009年9月分拆给股东。Jonas先生还担任拉斐尔控股公司（Rafael Holdings，Inc.）的董事会主席和首席执行官，该公司是IDT的前子公司，于2018年3月分拆给股东，自分拆后一直担任其董事会主席。Jonas先生自2013年4月起担任Rafael Pharmaceuticals，Inc.董事，并于2016年4月被任命为董事会主席。Jonas先生也是Jonas Media Group f/k/a Jonas Publishing自1979年成立以来的创始人和总裁。Jonas先生在哈佛大学获得了经济学学士学位。
Howard S. Jonas has been the Vice Chairman of Board of Directors since November 14, 2016. He was Chairman of the Board from June 2, 2016 until November 14, 2016 and has been a member of Board of Directors since May 23, 2016. Mr. Jonas founded IDT Corporation ("IDT") in Augt 1990 and has served as its Chairman of the Board of Directors since its inception. Howard S. Jonas served as Chief Executive Officer of IDT from October 2009 through December 2013 and from December 1991 until July 2001. Mr. Jonas is also the founder and has been President of Jonas Media Group (formerly Jonas Publishing) since its inception in 1979. From January 2014 until November 2017, Mr. Jonas served as the Chief Executive Officer of Genie Energy Ltd, a former subsidiary of IDT that was spun off to stockholders in October 2011; and has served as Chairman of the Board of Directors of Genie Energy since the spin off. Howard S. Jonas also serves as the Chairman of the Board and, until April 2020, the Chief Executive Officer of IDW Media Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in September 2009. Mr. Jonas also has served as the Chairman of the Board of Rafael Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in March 2018, since the spin off, and also as its Chief Executive Officer until May 2021. Howard S. Jonas received a B.A. in Economics from Harvard University. - Howard S. Jonas自2011年1月担任公司董事会主席，2014年1月至2017年11月担任公司首席执行官。他自2009年9月起担任公司子公司Genie Energy International Corporation董事会联席副主席。Jonas先生于1990年8月创立了IDT公司，自成立以来一直担任董事会主席。Jonas先生在2009年10月至2013年12月期间担任IDT首席执行官。Jonas先生担任Zedge，Inc.董事会主席，该公司是IDT的前子公司，于2016年6月至2016年11月分拆给股东，自2016年11月起担任Zedge董事会副主席。Jonas还担任IDW媒体控股公司（IDW Media Holdings，Inc.）董事会主席，该公司曾是IDT的子公司，2009年9月分拆给股东。Jonas先生还担任拉斐尔控股公司（Rafael Holdings，Inc.）的董事会主席和首席执行官，该公司是IDT的前子公司，于2018年3月分拆给股东，自分拆后一直担任其董事会主席。Jonas先生自2013年4月起担任Rafael Pharmaceuticals，Inc.董事，并于2016年4月被任命为董事会主席。Jonas先生也是Jonas Media Group f/k/a Jonas Publishing自1979年成立以来的创始人和总裁。Jonas先生在哈佛大学获得了经济学学士学位。
- Howard S. Jonas has been the Vice Chairman of Board of Directors since November 14, 2016. He was Chairman of the Board from June 2, 2016 until November 14, 2016 and has been a member of Board of Directors since May 23, 2016. Mr. Jonas founded IDT Corporation ("IDT") in Augt 1990 and has served as its Chairman of the Board of Directors since its inception. Howard S. Jonas served as Chief Executive Officer of IDT from October 2009 through December 2013 and from December 1991 until July 2001. Mr. Jonas is also the founder and has been President of Jonas Media Group (formerly Jonas Publishing) since its inception in 1979. From January 2014 until November 2017, Mr. Jonas served as the Chief Executive Officer of Genie Energy Ltd, a former subsidiary of IDT that was spun off to stockholders in October 2011; and has served as Chairman of the Board of Directors of Genie Energy since the spin off. Howard S. Jonas also serves as the Chairman of the Board and, until April 2020, the Chief Executive Officer of IDW Media Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in September 2009. Mr. Jonas also has served as the Chairman of the Board of Rafael Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in March 2018, since the spin off, and also as its Chief Executive Officer until May 2021. Howard S. Jonas received a B.A. in Economics from Harvard University.
高管简历
中英对照 | 中文 | 英文- David Polinsky
David Polinsky自2017年12月起担任公司首席财务官。Polinsky先生共同创立了Rafael Pharmaceuticals，自2002年起担任其Vice President，总法律顾问兼公司秘书，并于2016年至2018年3月担任总裁，总法律顾问兼秘书。他也曾任职Rafael Pharmaceutical公司的董事会（从2002年到2014年）。Polinsky先生担任Barer Institute，Inc.的财务主管。Polinsky先生还担任TheGiftbox的董事会主席，该公司是他在科技领域共同创立的公司，是Innovative Food Holdings Inc.的董事会成员。共同创立Rafael Pharmaceuticals公司之前，他曾担任总部位于纽约的专注于房地产的投资和管理公司Square Management Corp.的Vice President and General Counsel，领导住宅、办公、零售和开发物业的投资分析和管理。在此之前，Polinsky先生与纽约市前市长尊敬的Edward I.Koch合作，创立并担任一家许可和开发thelaw.com的公司的首席执行官。Polinsky先生于1996年在Fordham University School of Law获得法学博士学位，并在Yeshiva University获得文学学士学位。Polinsky先生还于2017年获得CFA Institute&8217；的投资基金会证书。
David Polinsky,has served as the Company's Chief financial Officer since January 28, 2023 and served as Chief of Staff from September 2021 through January 27, 2023. Mr. Polinsky previously served as Chief Financial Officer of the Company from December 2017 through September 2021. Mr. Polinsky co-founded Cornerstone Pharmaceuticals and served as its Vice President, General Counsel and Corporate Secretary from 2002 through 2018 and as its President, General Counsel and Secretary from 2016 through March 2018. He also served on Cornerstone Pharmaceutical's Board from 2002 until 2014. Mr. Polinsky is a member of the board of Connyct, Inc, Clinical Trials LLC and Negave Estates LLC. Previously, he served as Vice President and General Counsel for a New York-based real estate focused investment and management company, Square Management Corp., leading the investment analysis in and management of residential, office, retail and development properties. Previously and in partnership with the Honorable Edward I. Koch, former Mayor of New York City, Mr. Polinsky founded and served as CEO of a company that licensed and developed TheLaw.com. Mr. Polinsky earned his Juris Doctorate from Fordham University School of Law in 1996 and his Bachelor of Arts from Yeshiva University in 1993. Mr. Polinsky also earned the CFA Institute's Investment Foundations certificate in 2017, a certificate from MIT Sloan School of Management in Mastering Negotiation and Influence in 2021, and a certificate in 2022 from Columbia Business School in Blockchain in Business.- David Polinsky自2017年12月起担任公司首席财务官。Polinsky先生共同创立了Rafael Pharmaceuticals，自2002年起担任其Vice President，总法律顾问兼公司秘书，并于2016年至2018年3月担任总裁，总法律顾问兼秘书。他也曾任职Rafael Pharmaceutical公司的董事会（从2002年到2014年）。Polinsky先生担任Barer Institute，Inc.的财务主管。Polinsky先生还担任TheGiftbox的董事会主席，该公司是他在科技领域共同创立的公司，是Innovative Food Holdings Inc.的董事会成员。共同创立Rafael Pharmaceuticals公司之前，他曾担任总部位于纽约的专注于房地产的投资和管理公司Square Management Corp.的Vice President and General Counsel，领导住宅、办公、零售和开发物业的投资分析和管理。在此之前，Polinsky先生与纽约市前市长尊敬的Edward I.Koch合作，创立并担任一家许可和开发thelaw.com的公司的首席执行官。Polinsky先生于1996年在Fordham University School of Law获得法学博士学位，并在Yeshiva University获得文学学士学位。Polinsky先生还于2017年获得CFA Institute&8217；的投资基金会证书。
- David Polinsky,has served as the Company's Chief financial Officer since January 28, 2023 and served as Chief of Staff from September 2021 through January 27, 2023. Mr. Polinsky previously served as Chief Financial Officer of the Company from December 2017 through September 2021. Mr. Polinsky co-founded Cornerstone Pharmaceuticals and served as its Vice President, General Counsel and Corporate Secretary from 2002 through 2018 and as its President, General Counsel and Secretary from 2016 through March 2018. He also served on Cornerstone Pharmaceutical's Board from 2002 until 2014. Mr. Polinsky is a member of the board of Connyct, Inc, Clinical Trials LLC and Negave Estates LLC. Previously, he served as Vice President and General Counsel for a New York-based real estate focused investment and management company, Square Management Corp., leading the investment analysis in and management of residential, office, retail and development properties. Previously and in partnership with the Honorable Edward I. Koch, former Mayor of New York City, Mr. Polinsky founded and served as CEO of a company that licensed and developed TheLaw.com. Mr. Polinsky earned his Juris Doctorate from Fordham University School of Law in 1996 and his Bachelor of Arts from Yeshiva University in 1993. Mr. Polinsky also earned the CFA Institute's Investment Foundations certificate in 2017, a certificate from MIT Sloan School of Management in Mastering Negotiation and Influence in 2021, and a certificate in 2022 from Columbia Business School in Blockchain in Business.
- Howard S. Jonas
Howard S. Jonas自2011年1月担任公司董事会主席，2014年1月至2017年11月担任公司首席执行官。他自2009年9月起担任公司子公司Genie Energy International Corporation董事会联席副主席。Jonas先生于1990年8月创立了IDT公司，自成立以来一直担任董事会主席。Jonas先生在2009年10月至2013年12月期间担任IDT首席执行官。Jonas先生担任Zedge，Inc.董事会主席，该公司是IDT的前子公司，于2016年6月至2016年11月分拆给股东，自2016年11月起担任Zedge董事会副主席。Jonas还担任IDW媒体控股公司（IDW Media Holdings，Inc.）董事会主席，该公司曾是IDT的子公司，2009年9月分拆给股东。Jonas先生还担任拉斐尔控股公司（Rafael Holdings，Inc.）的董事会主席和首席执行官，该公司是IDT的前子公司，于2018年3月分拆给股东，自分拆后一直担任其董事会主席。Jonas先生自2013年4月起担任Rafael Pharmaceuticals，Inc.董事，并于2016年4月被任命为董事会主席。Jonas先生也是Jonas Media Group f/k/a Jonas Publishing自1979年成立以来的创始人和总裁。Jonas先生在哈佛大学获得了经济学学士学位。
Howard S. Jonas has been the Vice Chairman of Board of Directors since November 14, 2016. He was Chairman of the Board from June 2, 2016 until November 14, 2016 and has been a member of Board of Directors since May 23, 2016. Mr. Jonas founded IDT Corporation ("IDT") in Augt 1990 and has served as its Chairman of the Board of Directors since its inception. Howard S. Jonas served as Chief Executive Officer of IDT from October 2009 through December 2013 and from December 1991 until July 2001. Mr. Jonas is also the founder and has been President of Jonas Media Group (formerly Jonas Publishing) since its inception in 1979. From January 2014 until November 2017, Mr. Jonas served as the Chief Executive Officer of Genie Energy Ltd, a former subsidiary of IDT that was spun off to stockholders in October 2011; and has served as Chairman of the Board of Directors of Genie Energy since the spin off. Howard S. Jonas also serves as the Chairman of the Board and, until April 2020, the Chief Executive Officer of IDW Media Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in September 2009. Mr. Jonas also has served as the Chairman of the Board of Rafael Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in March 2018, since the spin off, and also as its Chief Executive Officer until May 2021. Howard S. Jonas received a B.A. in Economics from Harvard University.- Howard S. Jonas自2011年1月担任公司董事会主席，2014年1月至2017年11月担任公司首席执行官。他自2009年9月起担任公司子公司Genie Energy International Corporation董事会联席副主席。Jonas先生于1990年8月创立了IDT公司，自成立以来一直担任董事会主席。Jonas先生在2009年10月至2013年12月期间担任IDT首席执行官。Jonas先生担任Zedge，Inc.董事会主席，该公司是IDT的前子公司，于2016年6月至2016年11月分拆给股东，自2016年11月起担任Zedge董事会副主席。Jonas还担任IDW媒体控股公司（IDW Media Holdings，Inc.）董事会主席，该公司曾是IDT的子公司，2009年9月分拆给股东。Jonas先生还担任拉斐尔控股公司（Rafael Holdings，Inc.）的董事会主席和首席执行官，该公司是IDT的前子公司，于2018年3月分拆给股东，自分拆后一直担任其董事会主席。Jonas先生自2013年4月起担任Rafael Pharmaceuticals，Inc.董事，并于2016年4月被任命为董事会主席。Jonas先生也是Jonas Media Group f/k/a Jonas Publishing自1979年成立以来的创始人和总裁。Jonas先生在哈佛大学获得了经济学学士学位。
- Howard S. Jonas has been the Vice Chairman of Board of Directors since November 14, 2016. He was Chairman of the Board from June 2, 2016 until November 14, 2016 and has been a member of Board of Directors since May 23, 2016. Mr. Jonas founded IDT Corporation ("IDT") in Augt 1990 and has served as its Chairman of the Board of Directors since its inception. Howard S. Jonas served as Chief Executive Officer of IDT from October 2009 through December 2013 and from December 1991 until July 2001. Mr. Jonas is also the founder and has been President of Jonas Media Group (formerly Jonas Publishing) since its inception in 1979. From January 2014 until November 2017, Mr. Jonas served as the Chief Executive Officer of Genie Energy Ltd, a former subsidiary of IDT that was spun off to stockholders in October 2011; and has served as Chairman of the Board of Directors of Genie Energy since the spin off. Howard S. Jonas also serves as the Chairman of the Board and, until April 2020, the Chief Executive Officer of IDW Media Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in September 2009. Mr. Jonas also has served as the Chairman of the Board of Rafael Holdings, Inc., a former subsidiary of IDT that was spun off to stockholders in March 2018, since the spin off, and also as its Chief Executive Officer until May 2021. Howard S. Jonas received a B.A. in Economics from Harvard University.